Q3 2014 Holdings
Filed 2014-11-14 | 108 holdings | $158.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Idec, Inc.(BIIB) | Common | 09062X103 | $61.8M | 186,783 | 38.9% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $51.3M | 710,527 | 32.3% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $27.8M | 481,219 | 17.5% |
| Accuray, Inc.(ARAY) | Common | 004397105 | $5.3M | 731,943 | 3.3% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $4.8M | 61,595 | 3.0% |
| Align Technology, Inc.(ALGN) | Common | 016255101 | $3.6M | 70,400 | 2.3% |
| Agios Pharmaceuticals, Inc.(AGIO) | Common | 00847X104 | $2.1M | 35,000 | 1.4% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $265.1K | 2,490,531 | 0.2% |
| Celgene Corporation(CELG) | Common | 151020104 | $193.0K | 2,036,434 | 0.1% |
| Vertex Pharmaceuticals, Inc.(VRTX) | Common | 92532F100 | $78.8K | 701,944 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $74.9K | 451,905 | 0.0% |
| Amgen Inc.(AMGN) | Common | 031162100 | $71.6K | 510,042 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $67.5K | 187,166 | 0.0% |
| Actavis plc | Shares | G0083B108 | $67.0K | 277,631 | 0.0% |
| Pfizer, Inc.(PFE) | Common | 717081103 | $56.2K | 1,902,241 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $56.0K | 1,141,961 | 0.0% |
| Mylan, Inc. | Common | 628530107 | $46.0K | 1,010,105 | 0.0% |
| Allergan Inc. | Common | 018490102 | $40.7K | 228,227 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $37.6K | 229,341 | 0.0% |
| Teva Pharmaceutical Industries Ltd.(TEVA) | ADR | 881624209 | $35.1K | 652,194 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $34.9K | 327,212 | 0.0% |
| Cubist Pharmaceuticals, Inc. | Common | 229678107 | $32.8K | 494,454 | 0.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $32.5K | 266,875 | 0.0% |
| Shire plc | Sponsored ADR | 82481R106 | $31.9K | 123,322 | 0.0% |
| Aetna, Inc. | Common | 00817Y108 | $31.5K | 389,031 | 0.0% |
| Jazz Pharmaceuticals plc(JAZZ) | Shares | G50871105 | $27.8K | 173,241 | 0.0% |
| Bristol-Myers Squibb Co.(BMY) | Common | 110122108 | $27.4K | 535,240 | 0.0% |
| Akorn, Inc.(AKRXEUR) | Common | 009728106 | $25.4K | 699,382 | 0.0% |
| Impax Laboratories, Inc. | Common | 45256B101 | $23.5K | 990,283 | 0.0% |
| Endo International PLC | Shares | G30401106 | $23.0K | 336,215 | 0.0% |
| Ishares Nasdaq Biotechnology ETF(IBB) | ETF | 464287556 | $21.7K | 79,375 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $20.1K | 1,281,950 | 0.0% |
| Alkermes plc(ALKS) | Shares | G01767105 | $18.7K | 436,970 | 0.0% |
| Catamaran Corporation | Common | 148887102 | $18.3K | 433,600 | 0.0% |
| Celgene Corporation(CELG)Call | Common | 151020104 | $17.1K | 180,800 | 0.0% |
| Gilead Sciences, Inc.(GILD)Call | Common | 375558103 | $17.1K | 160,900 | 0.0% |
| Synageva BioPharma Corp. | Common | 87159A103 | $15.3K | 223,020 | 0.0% |
| Molina Healthcare, Inc.(MOH) | Common | 60855R100 | $14.7K | 347,901 | 0.0% |
| McKesson Corporation(MCK) | Common | 58155Q103 | $13.2K | 67,862 | 0.0% |
| Sagent Pharmaceuticals, Inc. | Common | 786692103 | $12.6K | 404,731 | 0.0% |
| Eli Lilly & Co(LLY) | Common | 532457108 | $12.1K | 186,918 | 0.0% |
| Momenta Pharmaceuticals, Inc.(MNTA) | Common | 60877T100 | $12.1K | 1,067,575 | 0.0% |
| Alere, Inc. | Common | 01449J105 | $11.6K | 297,901 | 0.0% |
| Health Care REIT Inc. | Common | 42217K601 | $11.4K | $200,000 | 0.0% |
| Cigna Corp | Common | 125509109 | $11.1K | 122,251 | 0.0% |
| Ironwood Pharmaceuticals, Inc.(IRWD) | Common | 46333X108 | $10.0K | 768,050 | 0.0% |
| Verastem, Inc. | Common | 92337C104 | $9.8K | 1,149,827 | 0.0% |
| Celladon Corporation | Common | 15117E107 | $9.6K | 970,495 | 0.0% |
| Perrigo Company plc(PRGO) | Shares | G97822103 | $9.5K | 62,952 | 0.0% |
| Acorda Therapeutics, Inc. | Common | 00484M106 | $9.3K | 273,162 | 0.0% |